http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Ahmad Soleimani,Mohsen Mahdavi Adeli,Farshad Zamani,Hamid Haghshenas Gorgani 국제구조공학회 2022 Steel and Composite Structures, An International J Vol.45 No.1
This research investigates a rotary disk with variable cross-section and incompressible hyperelastic material with functionally graded properties in large hyperelastic deformations. For this purpose, a power relation has been used to express the changes in cross-section and properties of hyperelastic material. So that (m) represents the changes in cross-section and (n) represents the manner of changes in material properties. The constants used for hyperelastic material have been obtained from experimental data. The obtained equations have been solved for different m, n, and (angular velocity) values, and the values of radial stresses, tangential stresses, and elongation have been compared. The results show that m and n have a significant impact on disk behavior, so the expected behavior of the disk can be obtained by an optimal selection of these two parameters.
HASSAN ADELI,SHARIF HUSSEIN SHARIF ZEIN,SOON HUAT TAN,ABDUL LATIF AHMAD 성균관대학교(자연과학캠퍼스) 성균나노과학기술원 2011 NANO Vol.6 No.2
In this study the response surface methodology (RSM) coupled with the central composite design (CCD) were used to optimize the mechanical strength properties of poly(L-lactide)/multi-walled carbon nanotube (MWCNT) scaffolds. The scaffolds were prepared by the freeze-extraction method. MWCNTs were incorporated into PLLA composite as a reinforcement agent in order to improve the strength properties of the scaffolds. The effect of process parameters such as ratio of PLLA/(PLLA + MWCNT) (93–100%), solvent amount (100–200 ml), freezing time (5–7 h) and immersing time (2–4 days) were studied using the design of experiment (DOE). Based on CCD, quadratic model was obtained and developed to correlate the process parameters to the strength of the scaffolds. An analysis of variance (ANOVA) was applied to determine the significant factors affecting the experimental design response (strength) of the scaffolds. The predicted values after optimization process were in good agreement with the experimental values. The model was able to accurately predict the response of strength with less than 5% error.
( Fatemeh Davami ),( Farzaneh Barkhordari ),( Mahmoud Alebouyeh ),( Ahmad Adeli ),( Fereidoun Mahboudi ) 한국미생물 · 생명공학회 2011 Journal of microbiology and biotechnology Vol.21 No.12
An important modification of thrombolytic agents is resistance to plasminogen activator inhibitor-1 (PAI-1). In previous studies, a new truncated PAI-1-resistant variant was developed based on deletion of the first three domains in t-PA and the substitution of KHRR 128-131 amino acids with AAAA in the truncated t-PA. The novel variant expressed in a static culture system of Chinese Hamster Ovary (CHO) DG44 cells exhibited a higher resistance to PAI-1 when compared with the full-length commercial drug; Actylase. In the present study, the truncatedmutant protein was expressed in CHO DG44 cells in 50 ml orbital shaking bioreactors. The final yield of the truncatedmutant in the culture was 752 IU/ml, representing a 63% increase compared with the static culture system. Therefore, these results suggest that using the combined features of a transient and stable expression system is feasible for the production of novel recombinant proteins in the quantities needed for preclinical studies.
( Azam Rahimpour ),( Behrouz Vaziri ),( Reza Moazzami ),( Leila Nematollahi ),( Farzaneh Barkhordari ),( Leila Kokabee ),( Ahmad Adeli ),( Fereidoun Mahboudi ) 한국미생물 · 생명공학회 2013 Journal of microbiology and biotechnology Vol.23 No.8
Cell line development is the most critical and also the most time-consuming step in the production of recombinant therapeutic proteins. In this regard, a variety of vector and cell engineering strategies have been developed for generating high-producing mammalian cells; however, the cell line engineering approach seems to show various results on different recombinant protein producer cells. In order to improve the secretory capacity of a recombinant tissue plasminogen activator (t-PA)-producing Chinese hamster ovary (CHO) cell line, we developed cell line engineering approaches based on the ceramide transfer protein (CERT) and X-box binding protein 1 (XBP1) genes. For this purpose, CERT S132A, a mutant form of CERT that is resistant to phosphorylation, and XBP1s were overexpressed in a recombinant t-PA-producing CHO cell line. Overexpression of CERT S132A increased the specific productivity of t-PA-producing CHO cells up to 35%. In contrast, the heterologous expression of XBP1s did not affect the t-PA expression rate. Our results suggest that CERTS132A- based secretion engineering could be an effective strategy for enhancing recombinant t- PA production in CHO cells.
Molecular Characterization of FLT3 Mutations in Acute Leukemia Patients
Ishfaq, Mariam,Malik, Arif,Faiz, Mariam,Sheikh, Ishfaq Ahmad,Asif, Muhammad,Khan, Muhammad Nasrullah,Qureshi, Muhammad Saeed,Zahid, Sara,Manan, Abdul,Arooj, Mahwish,Qazi, Mahmood Husain,Chaudhary, Ade Asian Pacific Journal of Cancer Prevention 2012 Asian Pacific journal of cancer prevention Vol.13 No.9
Fms-like tyrosine kinase 3 (FLT3) performs a vital role in the pathogenesis of hematopoietic malignancies. Therefore in recent times, the focus of several studies was on use of FLT3 as a prognostic marker. The present study investigated the molecular characterization and incidence of FLT3 mutations in acute leukemia patients in Pakistan. A total of 55 patients were studied, of which 25 were suffering from acute lymphoblastic leukemia (ALL) and 30 were suffering from acute myeloid leukemia (AML). The polymerase chain reaction demonstrated FLT3/ITD mutations in 1 (4%) of 25 ALL patients, a male with the L2 subtype. In AML cases the rate was 4 (13.3%) of 30, three males and one female. The AML-M4 subtype was found in three and the AML M2 subtype in the other. In the AML cases, a statistically significant (p=0.009) relationship was found between WBC (109/L) and FLT3/ITD positivity. However, no significant relationship was found with other clinical parameters (p>0.05). In acute myeloid leukemia (AML) $FLT3/ITD^+$ mutation was more prevalent in elderly patients 31-40 age groups, 21-30 and 51-60 age groups respectively. In acute lymphoblastic leukemia (ALL) statistically no significant relationship was found between clinical features and FLT3/ITD positivity (p>0.05). However, in acute lymphoblastic leukemia (ALL) $FLT3/ITD^+$ mutation was more commonly found in age groups of 21-30.
( Fatemeh Davami ),( Soroush Sardari ),( Keivan Majidzadeh A ),( Mahdi Hemayatkar ),( Farzaneh Barkhordari ),( Somayeh Enayati ),( Ahmad Adeli ),( Fereidoun Mahboudi ) 생화학분자생물학회(구 한국생화학분자생물학회) 2011 BMB Reports Vol.44 No.1
Resistance to PAI-1 is a factor which confers clinical benefits in thrombolytic therapy. The only US FDA approved PAI-1 resistant drug is Tenecteplase(R). Deletion variants of t-PA have the advantage of fewer disulfide bonds in addition to higher plasma half lives. A new variant was developed by deletion of the first three domains in t-PA in addition to substitution of KHRR 128-131 amino acids with AAAA in truncated t-PA. The specific activity of this new variant, 570 IU/μg, was found to be similar to those found in full length t-PA (Alteplase(R)), 580 IU/μg. A 65% and 85% residual activity after inhibition by rPAI-1 was observed for full length and truncated-mutant form, respectively. This new variant as the first PAI-1 resistant truncated t-PA may offer more advantages in clinical conditions in which high PAI-1 levels makes the thrombolytic system prone to re-occlusion. [BMB reports 2011; 44(1): 34-39]